Impact of genomics on therapeutic drug development
- 1 July 1997
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 41 (3-4) , 112-119
- https://doi.org/10.1002/(sici)1098-2299(199707/08)41:3/4<112::aid-ddr2>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Neurotactin, a membrane-anchored chemokine upregulated in brain inflammationNature, 1997
- Biotechnology: The Genomics GambleScience, 1997
- Accessing Genetic Information with High-Density DNA ArraysScience, 1996
- Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish familiesNature Genetics, 1996
- A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2Nature Genetics, 1996
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsJournal of Biological Chemistry, 1996
- Identification and Characterization of the Mouse Obesity Gene tubby: A Member of a Novel Gene FamilyCell, 1996
- A candidate gene for the mouse mutation tubbyNature, 1996
- Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activityNature Genetics, 1995
- Effects of parabiosis of obese with diabetes and normal miceDiabetologia, 1973